≡

Transforming Growth Factor Beta Receptor I (TGFbR1)

[Edit]

ACVRLK4; AAT5; ALK5; SKR4; TGFR-1; Activin A Receptor Type II-Like Kinase 53kDa; Activin receptor-like kinase 5; Serine/threonine-protein kinase receptor R4

Transforming Growth Factor Beta Receptor I (TGFbR1)
CCC A397
HGNC 11772
MGI 98728
PubMed 20813212
RGD 3852
UniProt P36897
Wiki TGFBR1

The protein encoded by this gene forms a heteromeric complex with type II TGF-beta receptors when bound to TGF-beta, transducing the TGF-beta signal from the cell surface to the cytoplasm. The encoded protein is a serine/threonine protein kinase. Mutations in this gene have been associated with Loeys-Dietz aortic aneurysm syndrome(LDAS).TGFB1 regulates cell cycle progression by a unique signaling mechanism that involves its binding to TGFBR2 and activation of TGFBR1. Both are transmembrane serine/threonine receptor kinases. The TGFBR1 receptor may be inactivated in many of the cases of human tumor cells refractory to TGFB-mediated cell cycle arrest. Vellucci and Reiss (1997) reported that the TGFBR1 gene is approximately 31 kb long and contains 9 exons.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPA397Hu01 Recombinant Transforming Growth Factor Beta Receptor I (TGFbR1) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAA397Hu01 Polyclonal Antibody to Transforming Growth Factor Beta Receptor I (TGFbR1) WB; IHC; ICC; IP.
MAA397Hu22 Monoclonal Antibody to Transforming Growth Factor Beta Receptor I (TGFbR1) WB; IHC; ICC; IP.
Assay Kits SEA397Hu ELISA Kit for Transforming Growth Factor Beta Receptor I (TGFbR1) Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPA397Mu01 Recombinant Transforming Growth Factor Beta Receptor I (TGFbR1) Positive Control; Immunogen; SDS-PAGE; WB.
RPA397Mu02 Recombinant Transforming Growth Factor Beta Receptor I (TGFbR1) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAA397Mu01 Polyclonal Antibody to Transforming Growth Factor Beta Receptor I (TGFbR1) WB; IHC; ICC; IP.
PAA397Mu02 Polyclonal Antibody to Transforming Growth Factor Beta Receptor I (TGFbR1) WB; IHC; ICC; IP.
Assay Kits SEA397Mu ELISA Kit for Transforming Growth Factor Beta Receptor I (TGFbR1) Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species: Rattus norvegicus (Rat)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Transforming Growth Factor Beta Receptor I (TGFbR1) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Transforming Growth Factor Beta Receptor I (TGFbR1) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Transforming Growth Factor Beta Receptor I (TGFbR1) Polyclonal Antibody Customized Service Offer
Assay Kits SEA397Ra ELISA Kit for Transforming Growth Factor Beta Receptor I (TGFbR1) Enzyme-linked immunosorbent assay for Antigen Detection.
  1. "Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor."Cell 75:681-692(1993) [PubMed] [Europe PMC] [Abstract]
  2. "Cloning and genomic organization of the human transforming growth factor-beta type I receptor gene."Genomics 46:278-283(1997) [PubMed] [Europe PMC] [Abstract]
  3. "DNA sequence and analysis of human chromosome 9." Nature 429:369-374(2004) [PubMed] [Europe PMC] [Abstract]
  4. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  5. "Type I transforming growth factor beta receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tract."Cancer Res. 58:2727-2732(1998) [PubMed] [Europe PMC] [Abstract]
  6. "Alternative splicing of TGF-betas and their high-affinity receptors T beta RI, T beta RII and T beta RIII (betaglycan) reveal new variants in human prostatic cells."BMC Genomics 8:318-318(2007) [PubMed] [Europe PMC] [Abstract]
  7. "GS domain mutations that constitutively activate T beta R-I, the downstream signaling component in the TGF-beta receptor complex."EMBO J. 14:2199-2208(1995) [PubMed] [Europe PMC] [Abstract]
  8. "MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma."Cell 86:543-552(1996) [PubMed] [Europe PMC] [Abstract]
  9. "MADR2 is a substrate of the TGFbeta receptor and its phosphorylation is required for nuclear accumulation and signaling."Cell 87:1215-1224(1996) [PubMed] [Europe PMC] [Abstract]
  10. "Mechanism of TGFbeta receptor inhibition by FKBP12."EMBO J. 16:3866-3876(1997) [PubMed] [Europe PMC] [Abstract]
  11. "TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4."EMBO J. 16:5353-5362(1997) [PubMed] [Europe PMC] [Abstract]
  12. "TbetaRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling."J. Biol. Chem. 272:27678-27685(1997) [PubMed] [Europe PMC] [Abstract]
  13. "SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor."Cell 95:779-791(1998) [PubMed] [Europe PMC] [Abstract]
  14. "Oligomeric structure of type I and type II transforming growth factor beta receptors: homodimers form in the ER and persist at the plasma membrane."J. Cell Biol. 140:767-777(1998) [PubMed] [Europe PMC] [Abstract]
  15. "Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF-beta receptor for degradation."Mol. Cell 6:1365-1375(2000) [PubMed] [Europe PMC] [Abstract]
  16. "Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation."J. Biol. Chem. 276:12477-12480(2001) [PubMed] [Europe PMC] [Abstract]
  17. "TLP, a novel modulator of TGF-beta signaling, has opposite effects on Smad2- and Smad3-dependent signaling."EMBO J. 22:4465-4477(2003) [PubMed] [Europe PMC] [Abstract]
  18. "NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor."Biochem. J. 386:461-470(2005) [PubMed] [Europe PMC] [Abstract]
  19. "Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity."Science 307:1603-1609(2005) [PubMed] [Europe PMC] [Abstract]
  20. "Identification of CD109 as part of the TGF-beta receptor system in human keratinocytes."FASEB J. 20:1525-1527(2006) [PubMed] [Europe PMC] [Abstract]
  21. "Potentiation of Smad-mediated transcriptional activation by the RNA-binding protein RBPMS."Nucleic Acids Res. 34:6314-6326(2006) [PubMed] [Europe PMC] [Abstract]
  22. "The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner."Nat. Cell Biol. 10:1199-1207(2008) [PubMed] [Europe PMC] [Abstract]
  23. "TGF-beta signal transduction."Annu. Rev. Biochem. 67:753-791(1998) [PubMed] [Europe PMC] [Abstract]
  24. "Large-scale proteomics analysis of the human kinome."Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed] [Europe PMC] [Abstract]
  25. "USP15 stabilizes TGF-beta receptor I and promotes oncogenesis through the activation of TGF-beta signaling in glioblastoma."Nat. Med. 18:429-435(2012) [PubMed] [Europe PMC] [Abstract]
  26. "Extracellular domain of type I receptor for transforming growth factor-beta: molecular modelling using protectin (CD59) as a template."FEBS Lett. 376:31-36(1995) [PubMed] [Europe PMC] [Abstract]
  27. "Crystal structure of the cytoplasmic domain of the type I TGF beta receptor in complex with FKBP12."Cell 96:425-436(1999) [PubMed] [Europe PMC] [Abstract]
  28. "The TGF beta receptor activation process: an inhibitor- to substrate-binding switch."Mol. Cell 8:671-682(2001) [PubMed] [Europe PMC] [Abstract]
  29. "Synthesis and activity of new aryl- and heteroaryl-substituted 5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole inhibitors of the transforming growth factor-beta type I receptor kinase domain."Bioorg. Med. Chem. Lett. 14:3581-3584(2004) [PubMed] [Europe PMC] [Abstract]
  30. "Identification of 1,5-naphthyridine derivatives as a novel series of potent and selective TGF-beta type I receptor inhibitors."J. Med. Chem. 47:4494-4506(2004) [PubMed] [Europe PMC] [Abstract]
  31. "Cooperative assembly of TGF-beta superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding."Mol. Cell 29:157-168(2008) [PubMed] [Europe PMC] [Abstract]
  32. "Ternary complex of transforming growth factor-beta1 reveals isoform-specific ligand recognition and receptor recruitment in the superfamily."J. Biol. Chem. 285:14806-14814(2010) [PubMed] [Europe PMC] [Abstract]
  33. "TGFBR1*6A and cancer risk: a meta-analysis of seven case-control studies."J. Clin. Oncol. 21:3236-3243(2003) [PubMed] [Europe PMC] [Abstract]
  34. "No major association between TGFBR1*6A and prostate cancer."BMC Genet. 5:28-28(2004) [PubMed] [Europe PMC] [Abstract]
  35. "A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2." Nat. Genet. 37:275-281(2005) [PubMed] [Europe PMC] [Abstract]
  36. "TGFBR1(*)6A is not associated with prostate cancer in men of European ancestry."Prostate Cancer Prostatic Dis. 8:50-53(2005) [PubMed] [Europe PMC] [Abstract]
  37. "FBN1, TGFBR1, and the Marfan-craniosynostosis/mental retardation disorders revisited."Am. J. Med. Genet. A 140:1047-1058(2006) [PubMed] [Europe PMC] [Abstract]
  38. "Identification and in silico analyses of novel TGFBR1 and TGFBR2 mutations in Marfan syndrome-related disorders."Hum. Mutat. 27:760-769(2006) [PubMed] [Europe PMC] [Abstract]
  39. "Aneurysm syndromes caused by mutations in the TGF-beta receptor." N. Engl. J. Med. 355:788-798(2006) [PubMed] [Europe PMC] [Abstract]
  40. "Patterns of somatic mutation in human cancer genomes." Nature 446:153-158(2007) [PubMed] [Europe PMC] [Abstract]
  41. "DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome." Nature 456:66-72(2008) [PubMed] [Europe PMC] [Abstract]
  42. "Loeys-Dietz syndrome type I and type II: clinical findings and novel mutations in two Italian patients."Orphanet J. Rare Dis. 4:24-24(2009) [PubMed] [Europe PMC] [Abstract]
  43. "Clinical features and genetic analysis of Korean patients with Loeys-Dietz syndrome."J. Hum. Genet. 57:52-56(2012) [PubMed] [Europe PMC] [Abstract]
  44. "Multiple self-healing squamous epithelioma is caused by a disease-specific spectrum of mutations in TGFBR1." Nat. Genet. 43:365-369(2011) [PubMed] [Europe PMC] [Abstract]